Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cerebrolysin for BBB in Diabetes and Ischemic Stroke
NCT06273020Phase 4Recruiting
- Sponsor
- Hospital Universitario Dr. Jose E. Gonzalez
- Start
- Nov 2022
- Primary completion
- Nov 2024
- Modality
- Native Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of cerebrolysin in ischemic stroke, sponsored by Hospital Universitario Dr. Jose E. Gonzalez. Started Nov 2022; status: recruiting.
02
Drugs
cerebrolysin
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT06273020.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06273020.